Global Cord Blood (NYSE:CO) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a research report report published on Wednesday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of CO stock opened at $1.20 on Wednesday. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50. The firm has a market capitalization of $145.86 million, a PE ratio of 1.88 and a beta of 0.16. The stock has a fifty day simple moving average of $1.31 and a two-hundred day simple moving average of $1.36.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.